|
2021
|
Invention
|
Retroviral vector for the administration and expression of replicon rna expressing heterologous n... |
|
2019
|
Invention
|
Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of u... |
|
|
Invention
|
Materials and methods for producing improved lentiviral vector particles. Materials and methods u... |
|
|
Invention
|
Vaccines for hsv-2.
Compositions of recombinant HSV-2 proteins and an agonist of the innate immu... |
|
|
Invention
|
Gla monotherapy for use in cancer treatment. The present disclosure relates generally to composit... |
|
2018
|
Invention
|
Multigenome retroviral vector preparations and methods and systems for producing and using same. ... |
|
|
Invention
|
Materials and methods for identifying and treating cancer patients. The present disclosure relate... |
|
2016
|
Invention
|
Vaccines for hsv-2. Compositions of recombinant HSV-2 proteins and an agonist of the innate immun... |
|
|
Invention
|
A retroviral vector for the administration and expression of replicon rna expressing heterologous... |
|
|
Invention
|
Compositions comprising lentiviral vectors expressing il-12 and methods of use thereof. This pate... |
|
|
Invention
|
Ny-eso-1 specific tcrs and methods of use thereof.
The present disclosure relates to NY-ESO-1 sp... |
|
|
Invention
|
Ny-eso-1 specific tcrs and methods of use thereof. The present disclosure relates to NY-ESO-1 spe... |
|
2015
|
Invention
|
Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein.
Lentiviral vector par... |
|
|
Invention
|
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector.
Compositions and meth... |
|
|
Invention
|
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector. Compositions and metho... |
|
|
Invention
|
Immunogenic composition and methods of using the compositions for inducing humoral and cellular i... |
|
|
Invention
|
Immunotherapy of cancer through combination of local and systemic immune stimulation.
Provided h... |
|
|
Invention
|
Immunotherapy of cancer through combination of local and systemic immune stimulation. Provided he... |
|
|
Invention
|
Compositions and methods for treating allergic conditions.
Compositions and methods are provided... |
|
|
Invention
|
Compositions for use in the treatment of allergic conditions. Compositions and methods are provid... |
|
|
Invention
|
Gla monotherapy for use in cancer treatment.
The present disclosure relates generally to composi... |
|
2014
|
Invention
|
Vaccine compositions for drug addiction.
The present invention relates generally to vaccines for... |
|
|
Invention
|
Vaccine compositions for drug addiction. The present invention relates generally to vaccines for ... |
|
2013
|
Invention
|
Lentiviral vector particles having improved transduction efficiency for cells expressing dc- sign... |
|
2012
|
Invention
|
Synthetic long peptide (slp)-based vaccines.
Synthetic long peptides and an adjuvant are formula... |
|
|
Invention
|
Synthetic long peptide (slp)-based vaccines. Synthetic long peptides and an adjuvant are formulat... |
|
|
Invention
|
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular ... |
|
|
Invention
|
Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles compris... |
|
|
Invention
|
Methods for enhancing immunogen specific immune responses by vectored vaccines.
Provided herein ... |
|
|
Invention
|
Methods for enhancing immunogen specific immune responses by vectored vaccines. Provided herein a... |
|
2011
|
Invention
|
Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein. Lentiviral vector part... |
|
|
Invention
|
Vaccines for pandemic influenza.
Pharmaceutical and vaccine compositions comprise recombinant he... |
|
|
Invention
|
Vaccines for pandemic influenza. Pharmaceutical and vaccine compositions comprise recombinant hem... |
